VEGFA and cancer: As shown in Figure S2 and Table S1, the high-risk group was enriched with pathways in cancer, cell cycle, adherens junction, MAPK signaling pathway, VEGF signaling pathway, and Wnt signaling pathway, indicating that the tumors of patients in the high-risk group were more proliferative and aggressive.